U.S. judge sentences Novelion's Aegerion in drug marketing case

BOSTON (Reuters) - A federal judge on Tuesday sentenced Aegerion Pharmaceuticals Inc for improperly marketing a cholesterol drug and ordered that some of the $40.1 million it agreed to pay to resolve a U.S. investigation go to the company's victims.

from Reuters: Health News http://ift.tt/2ntLcvd